BOSTON SCIENTIFIC CORP
BSXNYSE🏆 #189 by market capEarnings Oct 20 · PreUS Equity
$51.19▲ $0.74 (+1.45%)
Live1h—
24h▲ 1.4%
7d▲ 7.2%
14d▲ 11.2%
30d▲ 14.6%
1y▼ 50.1%
🏦Market Cap
$76.09B
Mid Cap
📈Revenue Growth (YoY)
+13.5%
Healthy
📊Gross Margin
69.8%
High
💵FCF Margin
16.5%
Healthy
⚖️P/S Ratio
3.5x
Fair
Otter Score
64
Fair
📊
Analyst Ratings
Price
$51.19
Total
44
Raised
5
Lowered
4
Avg PT
$65.47
| Institution | Action | Rating | Date |
|---|---|---|---|
Argus Research | Downgraded | Buy → Hold | 2026-07-31 |
Evercore ISI Group | Reiterated | Outperform | 2026-07-30 |
UBS | Reiterated | Buy | 2026-07-30 |
RBC Capital | Reiterated | Outperform | 2026-07-30 |
Citigroup | Reiterated | Buy | 2026-07-30 |
Truist Securities | Reiterated | Buy | 2026-07-30 |
TD Cowen | Reiterated | Buy | 2026-07-30 |
Wells Fargo | Reiterated | Equal Weight | 2026-07-30 |
Canaccord Genuity | Reiterated | Buy | 2026-07-30 |
BTIG | Reiterated | Buy | 2026-07-29 |
Oppenheimer | Reiterated | Outperform | 2026-07-27 |
Mizuho | Reiterated | Outperform | 2026-07-15 |
Needham | Reiterated | Buy | 2026-07-08 |
Stifel | Reiterated | Buy | 2026-06-25 |
Jefferies | Reiterated | Buy | 2026-06-24 |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2026-05-29 |
Leerink Partners | Reiterated | Outperform | 2026-05-28 |
Barclays | Reiterated | Overweight | 2026-05-28 |
Baird | Reiterated | Outperform | 2026-05-19 |
B of A Securities | Reiterated | Buy | 2026-05-18 |
Goldman Sachs | Reiterated | Buy | 2026-04-23 |
Raymond James | Downgraded | Strong Buy → Outperform | 2026-03-30 |
JP Morgan | Reiterated | Overweight | 2026-02-05 |
Morgan Stanley | Reiterated | Overweight | 2026-02-05 |
Piper Sandler | Reiterated | Overweight | 2025-02-03 |
Bernstein | Reiterated | Outperform | 2024-10-24 |
Deutsche Bank | Reiterated | Hold | 2024-07-25 |
SVB Leerink | Reiterated | Market Perform | 2022-04-28 |
Credit Suisse | Reiterated | Outperform | 2021-07-28 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-04-23 |
Stephens & Co. | Reiterated | Overweight | 2020-03-26 |
CFRA | Upgraded | Buy → Strong Buy | 2020-03-09 |
Cowen & Co. | Reiterated | Outperform | 2019-12-30 |
Argus | Reiterated | Buy | 2018-10-26 |
Leerink Swann | Reiterated | Outperform | 2018-04-26 |
Bank of America | Reiterated | Buy | 2018-04-05 |
BTIG Research | Upgraded | Neutral → Buy | 2017-11-30 |
BMO Capital | Reiterated | Outperform | 2017-10-27 |
Stifel Nicolaus | Reiterated | Buy | 2015-07-24 |
JMP Securities | Reiterated | Market Outperform | 2015-02-04 |
Benchmark | Upgraded | Hold → Buy | 2014-10-22 |
PiperJaffray | Upgraded | Neutral → Overweight | 2014-01-21 |
CL King | Downgraded | Strong Buy → Neutral | 2013-09-10 |
S&P Capital IQ | Upgraded | Hold → Buy | 2013-06-28 |
One row per institution, most recent rating